Improving Risk Prediction for T1D Onset: Modeling and Assay Development for Clinical and Commercial Use



Topic: Diabetes I

Destination: JDRF, the world’s leading non-profit organization with the mission to cure type 1 diabetes (T1D), invites Letters of Intent (LOI’s) for projects to improve risk prediction of T1D onset in two specific areas:

  • in silico modeling using existing genetic data to improve identification of the at-risk population
  • Integration of T1D Genetics or autoantibody testing into assay platforms that are commercially available as direct to consumer products or routinely used in clinical/public health laboratories

Budget: $600,000.

Duration: 2 years.

Estás interesado?

Llena el siguiente formulario para recibir más información: